Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SYNJ2 | O15056 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | ABL1 | P00519 | 1/20 | 0.55 |
| ▸ | ALPL | P05186 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | ALPI | P09923 | 1/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | ALPG | P10696 | 1/20 | 0.55 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | GALK1 | P51570 | 1/20 | 0.55 |
| ▸ | CASP7 | P55210 | 1/20 | 0.55 |
| ▸ | CASP6 | P55212 | 1/20 | 0.55 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.55 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.55 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.55 |
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.53 |
| ▸ | TYR | P14679 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7155388 | 1.00 | SYNJ2 (0.55) | SYNJ2KDM4EABL1ALPLPOLB | |
| SCHEMBL8604757 | 1.00 | SYNJ2 (0.55) | SYNJ2KDM4EABL1ALPLPOLB | |
| SCHEMBL8656458 | 1.00 | SYNJ2 (0.55) | SYNJ2KDM4EABL1ALPLPOLB | |
| SCHEMBL8718358 | 1.00 | SYNJ2 (0.55) | SYNJ2KDM4EABL1ALPLPOLB | |
| SCHEMBL14655998 | 0.98 | SYNJ2 (0.53) | SYNJ2KDM4EABL1ALPLPOLB | |
| SCHEMBL24837353 | 0.88 | SYNJ2 (0.55) | SYNJ2KDM4EABL1ALPLPOLB | |
| SCHEMBL4984171 | 0.88 | SYNJ2 (0.55) | SYNJ2KDM4EABL1ALPLPOLB | |
| SCHEMBL27757445 | 0.87 | SYNJ2 (0.54) | SYNJ2KDM4EABL1ALPLPOLB | |
| SCHEMBL3636324 | 0.85 | SYNJ2 (0.59) | SYNJ2KDM4EABL1ALPLPOLB | |
| SCHEMBL17296029 | 0.85 | SYNJ2 (0.56) | SYNJ2KDM4EABL1ALPLPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180118884-A1 | USE OF CO2 FOR THE SYNTHESIS OF CYCLIC GLYCOCARBONATES AND LINEAR POLYGLYCOCARBONATES BY POLYCONDENSATION FROM GLYCANS | UNIV KING ABDULLAH SCI & TECH (SA) | 2018-05-03 | — | — | US | disclosed |
| EP-3283498-A1 | USE OF CO2 FOR THE SYNTHESIS OF CYCLIC GLYCOCARBONATES AND LINEAR POLYGLYCOCARBONATES BY POLYCONDENSATION FROM GLYCANS | King Abdullah University Of Science And Technology (SA) | 2018-02-21 | — | — | EP | disclosed |
| WO-2016166682-A1 | USE OF CO2 FOR THE SYNTHESIS OF CYCLIC GLYCOCARBONATES AND LINEAR POLYGLYCOCARBONATES BY POLYCONDENSATION FROM GLYCANS | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2016-10-20 | — | — | WO | disclosed |
| US-5514662-A | HIV INFECTIONS | LABORATOIRES MAYOLY SPINDLER (S.A.R.L.) (FR) | 1996-05-07 | — | — | US | disclosed |
| WO-1993009791-A2 | USE OF AMPHOTERICIN B DERIVATIVES AS PROTEASE INHIBITORS | LABORATOIRES MAYOLY SPINDLER (S.A.R.L.) (FR) | 1993-05-27 | — | — | WO | disclosed |
| EP-0542630-A2 | Use of derivatives of amphotericin B as protease inhibitors | LABORATOIRES MAYOLY SPINDLER S.A.R.L. (FR) | 1993-05-19 | — | — | EP | disclosed |
| US-5095020-A | Antitumor agents | DUPHAR INTERNATIONAL RESEARCH B.V. (NL) | 1992-03-10 | — | — | US | disclosed |
| EP-0357122-A2 | Use of beta-carbolines, their bio-isosteric benzofuran and benzothiophene analogues for the manufacture of a medicament having cytostatic properties | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1990-03-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118884-A1 | USE OF CO2 FOR THE SYNTHESIS OF CYCLIC GLYCOCARBONATES AND LINEAR POLYGLYCOCARBONATES BY POLYCONDENSATION FROM GLYCANS | ALG1, CSGALNACT1, ALG8 | SYNJ2 1089/4885KDM4E 3568/4885ABL1 4729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.